Online inquiry

IVTScrip™ mRNA-Human ATP11B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28777MR)

This product GTTS-WK28777MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATP11B protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_014616.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23200
UniProt ID Q9Y2G3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATP11B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28777MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18453MR IVTScrip™ mRNA-Human Aminopeptidase-N, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Aminopeptidase-N
GTTS-WK23038MR IVTScrip™ mRNA-Human ATAD3A, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ATAD3A
GTTS-WK5323MR IVTScrip™ mRNA-Human DCLK1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA DCLK1
GTTS-WK13262MR IVTScrip™ mRNA-Human ABHD13, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ABHD13
GTTS-WK11373MR IVTScrip™ mRNA-Human ADSSL1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADSSL1
GTTS-WK24528MR IVTScrip™ mRNA-Human ASS1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ASS1
GTTS-WK14161MR IVTScrip™ mRNA-Human ABHD12B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABHD12B
GTTS-WK18336MR IVTScrip™ mRNA-Human AIMP2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AIMP2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW